Recombinant factor VIIa (rFVIIa) its effective at massive bleeding after caesarean section - A case report

被引:0
|
作者
Sokolic, V
Bukovic, D
Fures, R
Zadro, M
Scuric, I
Colak, F
Celovec, K
Bocan, A
机构
[1] Univ Zagreb, Ctr Hosp, Dept Obstet & Gynecol, Zagreb 10000, Croatia
[2] Gen Hosp Zabok, Dept Anesthesiol & Intens Care Med, Zabok, Croatia
[3] Ctr Hlth Zabok, Zabok, Croatia
关键词
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
A case of 31-year old woman who underwent emergency caesarean section (CS) following suspicion of the HELLP syndrome was reported. She developed arterial hypertension in 33(rd) week. In 38(th) week of her gestation elevated liver enzymes and positive albumin in urine were reported and pathological flow in umbilical artery and fetal aorta was found on ultrasound. The HELLP score was 12 and the HELLP syndrome was diagnosed. The pregnancy was terminated by CS for fetal distress and the HELLP syndrome. Two hours after the section she developed massive uterine bleeding with the signs of hemorrhagic shock. Despite of replacement therapy laboratory data worsened. DIC was diagnosed. Recombinant factor VIM was administrated; after several minutes bleeding decreased and laboratory data normalized.
引用
收藏
页码:155 / 157
页数:3
相关论文
共 50 条
  • [31] Recombinant factor VIIa: A useful tool for life-threatening colonic bleeding. Report of a case
    Mitchell, J. G.
    Speake, W. J.
    Russell, N. K.
    Girling, K.
    Armitage, N. C.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (12) : 2238 - 2240
  • [32] Case report: Management of life-threatening oro-pharyngeal bleeding with recombinant factor VIIa
    Riazi, Sheila
    Karkouti, Keyvan
    Heggie, Jane
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2006, 53 (09): : 881 - 884
  • [33] Recombinant factor VIIa (rFVIIa) as a safe and effective therapeutic option for the correction of moderate to severe hepatic coagulopathy.
    Wehbi, MA
    Obideen, K
    Martinez, E
    Duncan, A
    HEPATOLOGY, 2003, 38 (04) : 482A - 482A
  • [34] Massive postpartum haemorrhage & recombinant factor VIIA in Iceland: Report of five cases
    Klemenzson, G. K.
    Magnusdottir, E. M.
    Thorsteinsson, A.
    ANESTHESIOLOGY, 2007, 106 (05) : B95 - B95
  • [35] Usefulness of recombinant activated factor VII for massive bleeding due to trauma: a case report
    Franco Hernandez, Jose Antonio
    Niebles Velasquez, Rafael
    Cubian Gonzalez, Ignacio
    Garcia Hernandez, Alejandra
    EMERGENCIAS, 2011, 23 (01): : 73 - 74
  • [36] Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis
    Stefanovic, Branislav
    Stefanovic, Branislava
    Mijatovic, Srdjan
    Radenkovic, Dejan
    Popovic, Nada
    Sijacki, Ana
    Lackovic, Vesna
    VOJNOSANITETSKI PREGLED, 2009, 66 (11) : 928 - 932
  • [37] Recombinant factor VIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review
    Grounds, M
    BLOOD REVIEWS, 2003, 17 : S11 - S21
  • [38] Recombinant factor VIIa: life-saving therapy in a patient with massive bleeding and hepatic failure
    Storms, I.
    Zijlstra, M.
    Jacobs, E. M. G.
    Keeris, L. M.
    NETHERLANDS JOURNAL OF CRITICAL CARE, 2015, 19 (01): : 17 - 19
  • [39] Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli multidisciplinary rFVIIa task force
    Martinowitz, U
    Michaelson, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 640 - 648
  • [40] Recombinant factor VIIa for excessive bleeding after thrombectomy prior to kidney transplantation
    Sander, M
    von Heymann, C
    Kox, WJ
    Spies, CD
    Türk, I
    Loening, SA
    Ziemer, S
    TRANSPLANTATION, 2004, 77 (12) : 1912 - 1913